Guo Jing, Cao Xu, Li Zhiqiang, Wang Caiyu, Zhong Chengkun, Wang Simin, Fan Zhile, Zhao Jing, Wang Jun, Fang Yi, Liu Hongyu, Ding He, Ma Xin, Lu Wenfa
Key Lab of the Animal Production, Product Quality and Security, Ministry of Education, Jilin Agricultural University, Changchun, China.
Jilin Provincial International Joint Research Center of Animal Breeding and Reproduction Technology, Jilin Agricultural University, Changchun, China.
Front Vet Sci. 2024 Aug 8;11:1418091. doi: 10.3389/fvets.2024.1418091. eCollection 2024.
Postpartum endometritis is a prevalent reproductive disorder in bovines, leading to a prolonged open period, infertility, and other complications. While strains can mitigate these conditions by reducing uterine inflammation, their effectiveness is limited due to a lack of direct anti microbial action and extended treatment duration. This study aimed to construct a recombinant strain expressing bovine Granulocyte-macrophage colony-stimulating factor (GM-CSF) to evaluate its potential in reducing postpartum uterine inflammation.
The recombinant strain was engineered to express bovine GM-CSF and administered to pregnant mice via vaginal perfusion. Postpartum endometritis was induced using infection, and the protective effects of the engineered strain were assessed. Inflammatory markers (IL-6, IL-1β, TNF-α), myeloperoxidase (MPO) activity, and nitric oxide (NO) concentration were measured. Histological examination was performed to evaluate uterine morphology and pathological damage.
The recombinant strain expressing GM-CSF significantly reduced inflammation levels induced by infection in the uterus. This reduction was evidenced by decreased expression of IL-6, IL-1β, TNF-α, as well as reduced MPO activity and NO concentration. Histological examination revealed improved uterine morphology and reduced pathological damage in mice treated with the recombinant GM-CSF strain. Crucially, the recombinant strain also exerts beneficial effects on bovine endometritis by reducing levels of inflammatory cytokines, suggesting a beneficial effect on clinical bovine endometritis.
The recombinant expressing GM-CSF demonstrated protective effects against postpartum endometritis in bovines by reducing inflammatory cytokines. The findings indicate the potential clinical application of this engineered strain in preventing postpartum uterine inflammation, offering a novel and effective protective option for related disorders and improving bovine reproductive efficiency.
产后子宫内膜炎是牛群中一种常见的生殖系统疾病,会导致母牛空怀期延长、不孕以及其他并发症。虽然某些菌株可通过减轻子宫炎症来缓解这些状况,但其效果因缺乏直接抗菌作用和治疗时间较长而受到限制。本研究旨在构建一种表达牛粒细胞巨噬细胞集落刺激因子(GM-CSF)的重组菌株,以评估其在减轻产后子宫炎症方面的潜力。
构建能表达牛GM-CSF的重组菌株,并通过阴道灌注将其给予怀孕小鼠。利用感染诱导产后子宫内膜炎,评估该工程菌株的保护作用。检测炎症标志物(IL-6、IL-1β、TNF-α)、髓过氧化物酶(MPO)活性和一氧化氮(NO)浓度。进行组织学检查以评估子宫形态和病理损伤。
表达GM-CSF的重组菌株显著降低了子宫内感染诱导的炎症水平。这一降低表现为IL-6、IL-1β、TNF-α表达减少,以及MPO活性和NO浓度降低。组织学检查显示,用重组GM-CSF菌株处理的小鼠子宫形态改善,病理损伤减轻。至关重要的是,该重组菌株还通过降低炎症细胞因子水平对牛子宫内膜炎产生有益影响,表明对临床牛子宫内膜炎有有益作用。
表达GM-CSF的重组菌株通过降低炎症细胞因子对牛产后子宫内膜炎具有保护作用。研究结果表明该工程菌株在预防产后子宫炎症方面具有潜在的临床应用价值,为相关疾病提供了一种新颖有效的保护选择,并提高了牛的繁殖效率。